» Articles » PMID: 31006357

The Effect of Peripheral Blood Eosinophilia on Inflammatory Markers in Asthmatic Patients with Lower Respiratory Tract Infections

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2019 Apr 23
PMID 31006357
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To investigate the behaviour of the inflammatory marker neutrophil-to-lymphocyte ratio (NLR) in the presence of peripheral blood eosinophilia (PBE) in paediatric asthma patients with lower respiratory tract (LRT) infections.

Methods: This retrospective study enrolled consecutive patients aged ≥5 years who were diagnosed with asthma and whose haemogram values were available. The patients were further subdivided based on the presence or absence of LRT infections and allergies. NLR and C-reactive protein (CRP) were evaluated in relation to the presence or absence of PBE (≥4% eosinophils).

Results: A total of 991 patients were enrolled in the study. Patients with LRT infections had significantly higher leucocyte and neutrophil counts, a greater NLR and a higher level of CRP compared with patients without LRT infections. Overall, patients with PBE had significantly lower NLRs and CRP regardless of the presence or absence of an LRT infection. The PBE percentage showed moderate inverse correlations with NLR ( r = -0.34) and CRP ( r = -0.20).

Conclusion: The presence of PBE was significantly associated with lower NLR and CRP regardless of the presence or absence of an infectious condition.

Citing Articles

Neutrophil to lymphocyte ratio in pediatric patients with asthmatic exacerbation and community-acquired pneumonia.

Xu M, Zhou L, Zhang J, Luo S, Zhao Y, Xiong W BMC Pediatr. 2023; 23(1):640.

PMID: 38110898 PMC: 10726602. DOI: 10.1186/s12887-023-04456-6.


Severe Acute Bronchial Asthma with Sepsis: Determining the Status of Biomarkers in the Diagnosis of the Disease.

Sinha S, Kumar S, Narwaria M, Singh A, Haque M Diagnostics (Basel). 2023; 13(16).

PMID: 37627950 PMC: 10453001. DOI: 10.3390/diagnostics13162691.


Clinical Outcome of Eosinophilia in Patients with COVID-19: A Controlled Study.

Nair A, Soliman A, Al Masalamani M, De Sanctis V, Nashwan A, Sasi S Acta Biomed. 2021; 91(4):e2020165.

PMID: 33525219 PMC: 7927494. DOI: 10.23750/abm.v91i4.10564.


Inhibition of phosphodiesterase suppresses allergic lung inflammation by regulating MCP-1 in an OVA-induced asthma murine model with co-exposure to lipopolysaccharide.

Lee C, Choi W, Choi Y, Kang H, Lee W, Kim H J Int Med Res. 2020; 48(2):300060520903663.

PMID: 32054359 PMC: 7111082. DOI: 10.1177/0300060520903663.

References
1.
Galetto-Lacour A, Zamora S, Gervaix A . Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics. 2003; 112(5):1054-60. DOI: 10.1542/peds.112.5.1054. View

2.
Simon L, Gauvin F, Amre D, Saint-Louis P, Lacroix J . Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004; 39(2):206-17. DOI: 10.1086/421997. View

3.
Talbot T, Hartert T, Mitchel E, Halasa N, Arbogast P, Poehling K . Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005; 352(20):2082-90. DOI: 10.1056/NEJMoa044113. View

4.
Bateman E, Hurd S, Barnes P, Bousquet J, Drazen J, Fitzgerald J . Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008; 31(1):143-78. DOI: 10.1183/09031936.00138707. View

5.
Potter P . Current guidelines for the management of asthma in young children. Allergy Asthma Immunol Res. 2010; 2(1):1-13. PMC: 2831604. DOI: 10.4168/aair.2010.2.1.1. View